Our results tend to support these overall findings of reliable remodelling of DBM to new bone. The histological analysis showed significant new bone formation and decreasing residual DBM material in ...

Cerapedics, a privately-held orthobiologics company, announced today results from a pivotal FDA Investigational Device Exemption (IDE) clinical trial for i-FACTOR™ Peptide Enhanced Bone Graft in ...

BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec, a privately held spine and orthopedic technology company dedicated to creating safe and intuitive solutions for surgeons and patients, announced today ...

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the full market release and first implants ...

Please provide your email address to receive an email when new articles are posted on . The OssDsign Catalyst can now be used on-label in interbody cages cleared for use with synthetic bone grafts.

Pinnacle Transplant Technologies, Allografts, Tissue Bank, Graft, Spine Allograft Page, Sports Medicine Allografts, Sports Medicine Allografts, soft tissue PHOENIX ...

Ventris Medical’s Backpack contains bone particles designed to promote bone regeneration and healing following spinal fusion surgery Ventris Medical received 510(k) clearance for its bone graft ...

DePuy Synthes, a subsidiary of Johnson & Johnson (NYSE:JNJ), announced an exclusive distribution agreement with CGBIO for the ...

Nine patients (6 male and 3 female, 30 to 64 years old) that were scheduled for elective removal of dorsal instrumentation hardware over a 12-month time period were included in our study. Indications ...